AGE DISTRIBUTION OF LATENT HERPES-SIMPLEX VIRUS-1 AND VARICELLA-ZOSTER VIRUS GENOME IN HUMAN NERVOUS-TISSUE

被引:101
|
作者
LIEDTKE, W
OPALKA, B
ZIMMERMANN, CW
LIGNITZ, E
机构
[1] UNIV ESSEN GESAMTHSCH,FAC MED,DEPT MOLEC BIOL CANC RES,W-4300 ESSEN 1,GERMANY
[2] UNIV ESSEN GESAMTHSCH,FAC MED,DEPT FORENS MED,W-4300 ESSEN 1,GERMANY
关键词
HERPES SIMPLEX VIRUS-1; VARICELLA-ZOSTER VIRUS; POLYMERASE CHAIN REACTION (PCR); TRIGEMINAL GANGLION; OLFACTORY BULB; LATENT GENOME; AGE DISTRIBUTION;
D O I
10.1016/0022-510X(93)90082-A
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Latency in nervous tissue caused by herpes simplex virus 1 (HSV-1) and by varicella-zoster virus (VZV) is an intriguing feature of herpes-virus' neurotropism. HSV-1 and VZV latency are the causes of ophthalmic zoster and recurrent HSV infections in the distributions of the trigeminal branches. HSV-1 neuronal latency may play a role in the etiopathogenesis of HSV encephalitis. We attempted to determine the prevalence and age distribution of VZV and HSV latency. We applied nested polymerase chain reaction (PCR) assays to detect HSV-1 and VZV genome in trigeminal ganglia and olfactory bulbs which were obtained from 109 human corpses at forensic postmortems. HSV-1 latency was found in 72.5% of trigeminal ganglia and in 15.5% of olfactory bulbs. VZV latency was 63.3% in trigeminal ganglia and 1% in olfactory bulbs. Simultaneous latency of VZV and HSV genome occurs in 48.8% of trigeminal ganglia. The age-group specific prevalence of HSV neuronal latency increases from 18.2% in 0-20 years to reach finally 100% in persons older than 60 years. Age specific prevalences of VZV peaked for a first time with 82% between 21-30 years, fell to 50% for 40-50 years, and rose to 89% for 71-80 years. If the latent trigeminal ganglion HSV-1 genome were the source of endogenously acquired encephalitis, the peak incidence of HSV encephalitis in older subjects correlates with our findings. Increased VZV latency prevalence in nervous tissue of younger people without subsequent disease indicates sufficient immune surveillance.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 50 条
  • [21] ANTIBODIES AGAINST VARICELLA-ZOSTER VIRUS AND HERPES-SIMPLEX VIRUS DEOXYTHYMIDINE KINASE IN HETEROLOGOUS INFECTIONS
    KALLANDER, CFR
    TORFASON, EG
    OLDINGSTENKVIST, E
    SUNDQVIST, VA
    DIDERHOLM, H
    GRONOWITZ, JS
    JOURNAL OF MEDICAL VIROLOGY, 1989, 28 (01) : 30 - 37
  • [23] Varicella-zoster virus encephalitis resembling herpes simplex virus encephalitis
    Shindo, Atsuhiko
    Oyama, Genko
    Nishikawa, Noriko
    Hattori, Nobutaka
    BMJ CASE REPORTS, 2021, 14 (12)
  • [24] VARICELLA-ZOSTER VIRUS COMPLEMENTS HERPES-SIMPLEX VIRUS TYPE-1 TEMPERATURE-SENSITIVE MUTANTS
    FELSER, JM
    STRAUS, SE
    OSTROVE, JM
    JOURNAL OF VIROLOGY, 1987, 61 (01) : 225 - 228
  • [25] Antiviral Drugs for Varicella-Zoster Virus and Herpes Simplex Virus Infections
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1556): : 153 - 157
  • [26] Distribution of Latent Herpes Simplex Virus Type-1 and Varicella Zoster Virus DNA in Human Trigeminal Ganglia
    Randall J. Cohrs
    James J. Laguardia
    Donald Gilden
    Virus Genes, 2005, 31 : 223 - 227
  • [27] Distribution of latent herpes simplex virus type-1 and varicella zoster virus DNA in human trigeminal ganglia
    Cohrs, RJ
    Laguardia, JJ
    Gilden, D
    VIRUS GENES, 2005, 31 (02) : 223 - 227
  • [28] VARICELLA ZOSTER AND HERPES-SIMPLEX VIRUS-INFECTIONS
    GUREVICH, I
    HEART & LUNG, 1992, 21 (01): : 85 - 93
  • [29] Viable herpes simplex virus type 1 and varicella-zoster virus in the trigeminal ganglia of human cadavers
    Saitoh, Hisako
    Momma, Yuko
    Inoue, Hiroyuki
    Yajima, Daisuke
    Iwase, Hirotaro
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (05) : 833 - 838
  • [30] A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation
    Kennedy, Peter G. E.
    Rovnak, Joel
    Badani, Hussain
    Cohrs, Randall J.
    JOURNAL OF GENERAL VIROLOGY, 2015, 96 : 1581 - 1602